Public Release: 

Future Science Group announces free access to peer-reviewed journals focused on cancer

Future Science Group


IMAGE: This is the Future Science Group logo. view more

Credit: Future Science Group

2 April, 2015 - Future Science Group today announced that it will provide free access to three of its peer-reviewed, cancer-focused journals for the remainder of 2015. The journals, Hepatic Oncology, Melanoma Management, and the International Journal of Endocrine Oncology present the latest findings in their area of research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field.

"Given the critical importance of emerging research to every practitioner treating patients with cancer, we are very pleased to provide individuals with better access to new sources of quality information," said Phil Garner, Managing Director of Future Science Group. "While the journals are relatively new, each offers in depth coverage of an area of cancer that demands more attention and resources."

Hepatic Oncology publishes original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in both the adult and pediatric populations. The quarterly journal also highlights significant advances in basic and translational research, and places them in context for future therapy.

For more details please see:

Melanoma Management launched in August 2014 and focuses on the clinical aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. Published quarterly, Melanoma Management delivers an accessible overview of current and future melanoma management options in a concise format that is ideal for the busy clinician. The journal welcomes the unsolicited submission of article proposals and original research manuscripts.

For more details please see:

International Journal of Endocrine Oncology is a quarterly, peer-reviewed journal that helps the clinician to keep up to date with best practice in a fast-moving field that covers a broad range of diseases, both malignant and benign. It presents research findings in diagnosis and management of endocrine cancer, including tumors of hormone-secreting glands, such as the pituitary, thyroid, pancreatic and adrenal glands, along with neuroendocrine tumors. Independent drug evaluations assess newly approved medications and their role in clinical practice.

For more details please see:

All of the journals welcome the unsolicited submission of article proposals and original research manuscripts. Select content can be accessed from the whole of Future Science Group's Oncology collection. Plus, via Oncology Central, Future Science Group's free eCommunity for oncology professionals, users can access breaking news, articles and other essential current information, all aimed and selected by fellow trusted clinicians.


About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Oncology Central, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

About Oncology Central

Oncology Central is an online resource powered by Future Science Group designed to help members stay up-to-date with industry developments in the fast-paced field of oncology. Exclusively for oncology experts, Oncology Central is a free platform where news, peer-reviewed journal articles, multimedia, and exclusive content can be digested quickly and easily.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.